← Open Payments lookup

REBECCA BURKE: Open Payments

NPI 1982031514 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,335 in 160 payments from 17 companies in 2025. Trend: 2023 $2,397 · 2024 $3,061 · 2025 $3,335

Food & beverage: $3,327Education: $8
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$468
Otsuka America Pharmaceutical, Inc.20$446
Vanda Pharmaceuticals Inc.21$384
ABBVIE INC.19$351
Axsome Therapeutics, Inc.15$299
Neurocrine BioSciences, Inc.9$208
Takeda Pharmaceuticals U.S.A., Inc.11$203
Supernus Pharmaceuticals, Inc.8$202
Teva Pharmaceuticals USA, Inc.10$199
Janssen Pharmaceuticals, Inc9$161

Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, FANAPT, INGREZZA, TRINTELLIX, Qelbree.

Industry payments across AR — which companies pay providers there.